# Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

> **NCT01502813** · NA · COMPLETED · sponsor: **Deborah Yurgelun-Todd** · enrollment: 40 (actual)

## Conditions studied

- Cognitive Benefits

## Interventions

- **DRUG:** Citicoline, Omega-3 Fatty Acids and Creatine

## Key facts

- **NCT ID:** NCT01502813
- **Lead sponsor:** Deborah Yurgelun-Todd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02-01
- **Primary completion:** 2018-10-30
- **Final completion:** 2019-11-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01502813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01502813, "Citicoline, Creatine, and Omega-3 Effects in Middle Age Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01502813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*